Image

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder

Recruiting
18 - 70 years of age
Both
Phase N/A

Powered by AI

Overview

This is a single-center study about patients with severe resistant OCD.

Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex, and the cathode at the level of the supplementary motor area, associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms.

After the inclusion visit, the treatment period is provided from D1 to D12 (one session per day from Monday to Friday, for two consecutive weeks, i.e. a total of ten sessions). Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel.

The patients are then assessed on D42 and D102 (i.e. 1 month and 3 months after the end of the tDCS sessions).

Eligibility

Inclusion Criteria:

  • Patient suffering from OCD evolving for at least 2 years diagnosed according to DSM-V criteria;
  • Patient with good insight, defined by a score less than or equal to 18 at the threshold of delusions on the BABS (Brown Assessment of Beliefs Scale) insight scale;
  • Absence of a current depressive episode (MADRS score < 21) or suicidal risk (MADRS score item 10 < 3);
  • Absence of epileptic pathology;
  • Chronic obsessive-compulsive disorder defined by a total YBOCS score > 20, or a subscale score > 15;
  • Drug-resistant obsessive-compulsive disorder despite treatment with:
    1. at least 2 antidepressants of the IRS type at an effective dose and for a sufficient duration
    2. and/or Behavioral and Cognitive therapy for at least 1 year;
  • Therapeutic stability (antidepressants) for more than 12 weeks without significant

    improvement. This treatment, at a fixed dose, will be maintained during the study;

  • Patient aged between 18 and 70 included
  • Patient who has given his/her informed consent after having received written information on the planned procedure;
  • Patient benefiting from social security or by benefiting through a third party.

Exclusion Criteria:

  • Woman of childbearing age without effective means of contraception (hormonal/mechanical: oral, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy)
  • Pregnant or nursing woman;
  • Patient hospitalized under duress (SPDT, SPDRE);
  • Patient under guardianship or curatorship;
  • Patient with another DSM-V Axis 1 diagnosis (Schizophrenic Disorder, Bipolar Disorder, Substance Abuse or Substance Dependence).
        Generalized anxiety disorder, social phobia, nicotine addiction and history of major
        depressive episodes are not exclusion criteria. Axis I comorbidity will be explored using
        MINI 5.0.0. ;
          -  Patient suffering from a current depressive episode;
          -  Patient at risk of suicide;
          -  Patient with skin lesions on the scalp;
          -  History of head trauma;
          -  Patient with an intracerebral metal object
          -  Patient with a pacemaker;
          -  Presence of epileptic pathology;
          -  Patient in an emergency situation or unable to give personal consent

Study details

Obsessive-Compulsive Disorder

NCT06017713

Centre Hospitalier Henri Laborit

23 February 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.